Italy: public pharmaceutical expenditure in 2016, by ATC

This statistic illustrates the levels of public pharmaceutical expenditure in Italy in 2016, by ATC. According to data, most of the spending was, addressed to antineoplastic and immunomodulatory drugs and to antimicrobial for systemic use. The therapeutic class with the lowest level of expenditure was instead, the one including anti-parasitic products, insecticides and repellents.

本统计数据展示了2016年意大利公共药品支出的水平，按ATC分类。据数据表明，大部分支出用于抗肿瘤和免疫调节药物，以及全身性使用的抗菌药物。然而，支出最低的治疗类别则包括抗寄生虫产品、杀虫剂和驱蚊剂。